Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01268072 · ClinicalTrials.gov registry record
A Study to Evaluate Biomarkers in Chronic Obstructive Pulmonary Disease
A clinical trial, sponsored by MedImmune.
- Terminated
- Registry status
- 61
- Enrollment target
NCT01268072: Clinical Trial study, sponsored by MedImmune.
NCT01268072 is a clinical trial that was terminated before completion, run by MedImmune. The registered enrollment target is 61 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01268072 was terminated before completion, sponsored by MedImmune.
- TERMINATED
- Registry status
- 61 participants
- Enrollment target
Study Summary
The primary objective of this study is to identify biomarkers that can be used for evaluation of efficacy in subjects presenting with AECOPD
Primary Outcome
Investigate changes in physiological measures, symptoms, and blood, urine and sputum biomarkers in subjects with stable COPD during AECOPD, and as subjects return to clinical stability.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2011-02 |
| Est. Completion | 2013-01 |
Why NCT01268072 stopped before completion
NCT01268072 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 61 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01268072 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01268072 about?
NCT01268072 is a clinical study titled "A Study to Evaluate Biomarkers in Chronic Obstructive Pulmonary Disease". The primary objective of this study is to identify biomarkers that can be used for evaluation of efficacy in subjects presenting with AECOPD
What is the current status of trial NCT01268072?
This trial is currently terminated. The enrollment target is 61 participants. The study started on 2011-02. Estimated completion is 2013-01.
Who is sponsoring clinical trial NCT01268072?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia